{"id":"elemene","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Vomiting"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"β-elemene has been found to exert its anti-cancer effects through multiple mechanisms, including the inhibition of the PI3K/AKT signaling pathway and the induction of cell cycle arrest. Additionally, β-elemene has been shown to have anti-inflammatory and anti-oxidative properties, which may contribute to its anti-cancer effects.","oneSentence":"β-elemene is a sesquiterpene compound that has been shown to have anti-cancer properties through the inhibition of cell proliferation and induction of apoptosis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:10:49.129Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer"},{"name":"Breast cancer"}]},"trialDetails":[{"nctId":"NCT02629757","phase":"PHASE3","title":"A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-04","conditions":"Anaplastic Oligoastrocytoma, Anaplastic Astrocytoma, Glioblastoma","enrollment":100},{"nctId":"NCT03123484","phase":"PHASE2","title":"β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC","status":"UNKNOWN","sponsor":"China Medical University, China","startDate":"2017-04","conditions":"Non Small Cell Lung Cancer","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":754,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["elemene liposomes"],"phase":"phase_3","status":"active","brandName":"β-elemene","genericName":"β-elemene","companyName":"Sun Yat-sen University","companyId":"sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"β-elemene is a sesquiterpene compound that has been shown to have anti-cancer properties through the inhibition of cell proliferation and induction of apoptosis. Used for Non-small cell lung cancer, Breast cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}